SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001683168-24-003171
Filing Date
2024-05-09
Accepted
2024-05-09 17:28:44
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 cnspharma_s3.htm S-3 266156
2 FORM OF UNSUBORDINATED INDENTURE cns_ex0401.htm EX-4.1 512256
3 FORM OF SUBORDINATED INDENTURE cns_ex0402.htm EX-4.2 570828
4 CONSENT OF ARENTFOX SCHIFF LLP cns_ex0500.htm EX-5 30771
5 CONSENT OF MALONEBAILEY, LLP cns_ex2301.htm EX-23.1 2950
6 CALCULATION OF FILING FEE TABLES cns_ex107.htm EX-FILING FEES 30287
7 GRAPHIC image_001.jpg GRAPHIC 3500
8 GRAPHIC image_002.jpg GRAPHIC 6844
9 GRAPHIC image_003.jpg GRAPHIC 1560
  Complete submission text file 0001683168-24-003171.txt   1431093
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279285 | Film No.: 24932066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)